• L-NAME Hydrochloride: Advanced NOS Inhibition for Vascular S

  2026-07-22

  L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) is the gold-standard NOS inhibitor for dissecting nitric oxide pathways in cardiovascular and inflammation research. This guide delivers actionable protocols, troubleshooting insights, and key translational lessons from recent studies, ensuring data-driven precision for vascular tone and hypertension models.

• Intra- and Extracellular Dicloxacillin Activity Against MSSA

  2026-07-22

  This study systematically examines dicloxacillin's efficacy against methicillin-sensitive Staphylococcus aureus (MSSA) in both intra- and extracellular environments, using complementary in vitro and in vivo models. The findings clarify the antibiotic's pharmacodynamic behavior and inform protocol optimization for Gram-positive bacterial infection research.

• Rapid LC–MS/MS Quantification of Cefazedone & Etimicin: PK A

  2026-07-21

  This study introduces a validated ultra fast liquid chromatography–tandem mass spectrometry (UFLC–MS/MS) method for simultaneous measurement of cefazedone and etimicin in beagle dog plasma. The method enhances pharmacokinetic analysis of combination antibiotic therapy, supporting optimized dosing strategies and safety assessment in preclinical models.

• Applied Workflows with Polymyxin B Sulfate: From Infection M

  2026-07-21

  Polymyxin B sulfate enables researchers to model multidrug-resistant Gram-negative infections while simultaneously probing immune modulation in vitro and in vivo. This article details practical experimental protocols, troubleshooting insights, and novel applications, leveraging APExBIO’s trusted supply of Polymyxin B (sulfate) for advanced microbiology and immunology research.

• In Vitro Efficacy of Temafloxacin Against Gram-Negative Path

  2026-07-20

  This article reviews a foundational study comparing Temafloxacin’s in vitro antibacterial activity with ciprofloxacin and ofloxacin across diverse gram-negative bacteria. The reference paper establishes Temafloxacin’s low MICs for key respiratory and enteric pathogens, supporting its value as a fluoroquinolone broad-spectrum antibacterial agent for infection biology research.

• Artemisia argyi Oil Boosts Thermogenesis to Counter Diet-Ind

  2026-07-20

  This study reveals that Artemisia argyi oil (AAO) significantly reduces high-fat diet-induced obesity in mice by enhancing thermogenesis in brown adipose tissue (BAT). The mechanism involves upregulation of Ucp1 through ZFP516 activation, offering new insights into dietary modulation of energy metabolism.

• Aztreonam (SKU A5931): Reliable Research Tool for Gram-Negat

  2026-07-19

  This article addresses real-world laboratory challenges in Gram-negative resistance assays and metabolic studies, highlighting how Aztreonam (SKU A5931) provides validated, reproducible solutions for cell viability and enzyme interaction workflows. Practical Q&A scenarios, protocol optimization tips, and comparative product insights guide researchers toward robust experimental outcomes with Aztreonam.

• Dual Luciferase Reporter Gene System: Precision Tools for De

  2026-07-18

  Explore how the Dual Luciferase Reporter Gene System empowers researchers to unravel complex lncRNA-mediated transcriptional regulation. Delve into advanced assay optimization and practical insights inspired by recent breakthroughs, offering a unique edge for gene expression regulation studies.

• Antibacterial Use and Resistance Trends in Psychiatric Hospi

  2026-07-17

  This study provides a detailed analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the COVID-19 epidemic, highlighting both rational antibiotic stewardship and emerging resistance challenges. Its findings underscore the need for continuous monitoring and tailored antimicrobial policies in specialized healthcare settings.

• Carbapenemase Gene Dynamics in CREC Across Guangdong Hospita

  2026-07-17

  This study provides a detailed molecular epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) collected from eight teaching hospitals in Guangdong, China (2022–2024). The findings reveal a high prevalence of blaNDM-1 and highlight the plasmid-mediated transmission of multidrug resistance, offering critical insights for antimicrobial resistance surveillance and laboratory assay design.

• Allosteric PDK4 Inhibitors: Advancing Metabolic Disease Ther

  2026-07-16

  This study identifies a new series of allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), with the lead compound 8c demonstrating potent in vitro and in vivo efficacy for metabolic disease models. The findings offer a validated scaffold for further drug development and highlight the therapeutic potential of PDK4 modulation in metabolic, allergic, and cancer contexts.

• Sabutoclax as a Pan-Bcl-2 Inhibitor: Precision Tools for Dis

  2026-07-16

  Explore how Sabutoclax, a potent pan-Bcl-2 inhibitor, enables nuanced analysis of apoptosis in cancer cells. This article reveals advanced strategies for distinguishing cell death from proliferation arrest, with practical insights for high-fidelity preclinical modeling.

• Biotin-HPDP in Thiol-Specific Protein Labeling: Protocols &

  2026-07-15

  Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide) delivers reversible, high-sensitivity thiol-specific protein biotinylation for redox biology, S-nitrosylated protein detection, and advanced affinity workflows. This guide translates recent breakthroughs in cysteine palmitoylation and pyroptosis into actionable experimental strategies, troubleshooting, and protocol optimization.

• Haloprogin’s Broad-Spectrum Antifungal and Antibacterial Eff

  2026-07-15

  The reference study systematically establishes Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as a potent topical antimicrobial with robust in vitro and in vivo activity against dermatophytes, Candida species, and select Gram-positive bacteria. Its comparative evaluation with tolnaftate highlights Haloprogin’s unique spectrum and informs protocol design for dermatophytosis and Candida albicans infection research.

• CH 223191: Potent AhR Antagonist for Dioxin Toxicity Studies

  2026-07-14

  CH 223191 is a highly selective aryl hydrocarbon receptor antagonist validated for dissecting dioxin toxicity and AhR signaling with nanomolar potency. Its efficacy in modulating CYP1A1 expression and reducing TCDD-induced hepatic toxicity makes it a benchmark tool for environmental toxicology and regeneration research.

414 records 8/28 page Previous Next First page 上5页 678910 下5页 Last page